Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan

Leeuwenhoek Laboratories Co. Ltd.

Status: Not yet enrolling

Conditions: Metabolic Syndrome

Study type: Observational

Funder types: Industry

Identifiers

NCT06363864

LL-IRB-2401

Details and patient eligibility

About

The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.

Enrollment: 1,200 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Capable adults weigh ≥ 50 kg

Exclusion criteria

• Not Taiwanese
• Having received oral antibiotics, immunosuppressants, and chemotherapy drugs in the past month
• Incapacity
• Limited disposing capacity
• Mental disorders or intellectual disabilities

Trial design

1,200 participants in 2 patient groups

Healthy individuals

Metabolic syndrome patients